Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Am Cuddy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Journal of Internal Medicine|February 21, 2026
How to monitor disease progression in ATTR amyloid cardiomyopathy: Implications for clinical practice and trial designAldostefano Porcari, Sarah Am Cuddy, Marco Metra, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 16, 2026
Quantitative cardiac amyloid radionuclide imagingRobert Jh Miller, Olivier F Clerc, Sarah Am Cuddy, et al.
Blood|July 25, 2025
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain AmyloidosisPedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, et al.
Future Cardiology|February 9, 2026
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CMNitasha Sarswat, Amrut V Ambardekar, Kevin M Alexander, et al.
Circulation. Cardiovascular Imaging|November 15, 2022
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac AmyloidosisSarah Am Cuddy, Yesh Datar, Gavin Ovsak, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Prognostic Value of Left Ventricular <sup>18</sup> F-Florbetapir Uptake in Systemic Light-Chain AmyloidosisOlivier F Clerc, Yesh Datar, Sarah Am Cuddy, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Journal of Internal Medicine|February 21, 2026
How to monitor disease progression in ATTR amyloid cardiomyopathy: Implications for clinical practice and trial designAldostefano Porcari, Sarah Am Cuddy, Marco Metra, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 16, 2026
Quantitative cardiac amyloid radionuclide imagingRobert Jh Miller, Olivier F Clerc, Sarah Am Cuddy, et al.
Blood|July 25, 2025
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain AmyloidosisPedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, et al.
Future Cardiology|February 9, 2026
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CMNitasha Sarswat, Amrut V Ambardekar, Kevin M Alexander, et al.
Circulation. Cardiovascular Imaging|November 15, 2022
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac AmyloidosisSarah Am Cuddy, Yesh Datar, Gavin Ovsak, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Prognostic Value of Left Ventricular <sup>18</sup> F-Florbetapir Uptake in Systemic Light-Chain AmyloidosisOlivier F Clerc, Yesh Datar, Sarah Am Cuddy, et al.
Pageof 1